Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rostafuroxin

Known as: 17-(3-furyl)-5beta-androstane-3,14,17-triol 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Androstanols

Narrower (1)

PST 2238

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Ouabain–digoxin antagonism in rat arteries and neurones
‘Classic’ cardiotonic steroids (CTSs) all inhibit Na+,K+‐ATPase (Na+ pumps) and exert cardiotonic and vasotonic effects… Expand
Review
2012
Review
2012
Systemic Hypertension: The Roles of Salt, Vascular Na+/K+ ATPase and the Endogenous Glycosides, Ouabain and Marinobufagenin
Essential hypertension has been shown to be significantly associated with an increased risk for cardiovascular disease and is not… Expand
Highly Cited
2011
Highly Cited
2011
Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase α3 sodium pump
Bipolar disorder is a debilitating psychopathology with unknown etiology. Accumulating evidence suggests the possible involvement… Expand
  • figure 2
  • figure 1
  • figure 1
  • figure 2
  • figure 3
2011
2011
Main results of the Ouabain and Adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin
BackgroundThe Ouabain and Adducin for Specific Intervention on Sodium in Hypertension (OASIS-HT) Trial was a phase-2 dose-finding… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Highly Cited
2010
Highly Cited
2010
Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin, Part 2: Clinical Studies
Five genetic variants that affect Na,K-ATPase interactions predict the blood pressure response to rostafuroxin but not to… Expand
Review
2010
Review
2010
Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension.
  • P. Ferrari
  • Biochimica et biophysica acta
  • 2010
    • Corpus ID: 19192222
An innovative approach to the therapy of essential hypertension (EH) and the related complications has been pursued by our group… Expand
  • figure 1
  • table 1
2010
2010
Adducin- and Ouabain-Related Gene Variants Predict the Antihypertensive Activity of Rostafuroxin, Part 1: Experimental Studies
Rostafuroxin lowers blood pressure in rats and disrupts mutant α-adducin and ouabain–Na,K-ATPase complex interaction with the Src… Expand
2009
2009
Left ventricular geometry and endogenous ouabain in a Flemish population
Background Endogenous ouabain, an endogenous digitalis-like steroid, is synthesized in the adrenal glands and possibly in the… Expand
Review
2007
Review
2007
Endogenous and Exogenous Cardiac Glycosides and their Mechanisms of Action
Cardiac glycosides have been used for decades to treat congestive heart failure. The recent identification of cardiotonic… Expand
Review
2006
Review
2006
Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.
The genetic and environmental heterogeneity of essential hypertension is responsible for the individual variability of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE